Kalobios Pharmaceuticals, Inc.
About:
KaloBios Pharmaceuticals is a biotechnology company that develops advancing medicines for patients.
Website: https://www.kalobios.com
Top Investors: Sofinnova Investments, Mitsubishi UFJ Capital, Baxter International, MPM Capital, 5AM Ventures
Description:
KaloBios Pharmaceuticals provides medicines for respiratory diseases and certain cancers. The company is a biopharmaceutical company focused on advancing medicines for patients with neglected and rare diseases. They designed to overcome marketed antibody products.
Total Funding Amount:
$83.9M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
South San Francisco, California, United States
Founded Date:
2000-03-15
Founders:
Number of Employees:
11-50
Last Funding Date:
2020-07-01
IPO Status:
Public
Industries:
© 2025 bioDAO.ai